Free Access
Med Sci (Paris)
Volume 21, Number 2, Février 2005
Page(s) 170 - 174
Section M/S revues
Published online 15 February 2005
  1. Stenson PD, Ball EV, Mort M, et al. Human gene mutation database (HGMD) : 2003 update. Hum Mutat 2003; 21 : 577–81. [Google Scholar]
  2. Ars E, Serra E, Garcia J, et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 2000; 9 : 237–47. [Google Scholar]
  3. Teraoka SN, Telatar M, Becker-Catania S, et al. Splicing defects in the ataxia-telangiectasia gene, ATM : underlying mutations and consequences. Am J Hum Genet 1999; 64 : 1617–31. [Google Scholar]
  4. Cooper TA, Mattox W. The regulation of splice-site selection, and its role in human disease. Am J Hum Genet 1997; 61 : 259–66. [Google Scholar]
  5. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense : exonic mutations that affect splicing. Nat Rev Genet 2002; 3 : 285–98. [Google Scholar]
  6. Yang Y, Swaminathan S, Martin BK, Sharan SK. Aberrant splicing induced by missense mutations in BRCA1 : clues from a humanized mouse model. Hum Mol Genet 2003; 12 : 2121–31. [Google Scholar]
  7. Cartegni L, Krainer AR. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002; 30 : 377–84. [Google Scholar]
  8. Kashima T, Manley JL. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 2003; 34 : 460–3. [Google Scholar]
  9. Cogan JD, Prince MA, Lekhakula S, et al. A novel mechanism of aberrant pre-mRNA splicing in humans. Hum Mol Genet 1997; 6 : 909–12. [Google Scholar]
  10. Pagani F, Stuani C, Tzetis M, et al. New type of disease causing mutations : the example of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum Mol Genet 2003; 12 : 1111–20. [Google Scholar]
  11. Chao HK, Hsiao KJ, Su TS. A silent mutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria. Hum Genet 2001; 108 : 14–9. [Google Scholar]
  12. Hefferon TW, Groman JD, Yurk CE, Cutting GR. A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing. Proc Natl Acad Sci USA 2004; 101 : 3504–9. [Google Scholar]
  13. Buratti E, Brindisi A, Pagani F, Baralle FE. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9 : a functional link with disease penetrance. Am J Hum Genet 2004; 74 : 1322–5. [Google Scholar]
  14. Sakai T, Ohtani N, McGee TL, et al. Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature 1991; 353 : 83–6. [Google Scholar]
  15. Ohtani-Fujita N, Fujita T, Takahashi R, et al. A silencer element in the retinoblastoma tumor-suppressor gene. Oncogene 1994; 9 : 1703–11. [Google Scholar]
  16. Price P, Wong AM, Williamson D, et al. Polymorphisms at positions -22 and -348 in the promoter of the BAT1 gene affect transcription and the binding of nuclear factors. Hum Mol Genet 2004; 13 : 967–74. [Google Scholar]
  17. Liu L, Dilworth D, Gao L, et al. Mutation of the CDKN2A 5’ UTR creates an aberrant initiation codon and predisposes to melanoma. Nat Genet 1999; 21 : 128–32. [Google Scholar]
  18. Cazzola M, Skoda RC. Translational pathophysiology : a novel molecular mechanism of human disease. Blood 2000; 95 : 3280–8. [Google Scholar]
  19. Marlin S, Blanchard S, Slim R, et al. Townes-Brocks syndrome : detection of a SALL1 mutation hot spot and evidence for a position effect in one patient. Hum Mutat 1999; 14 : 377–86. [Google Scholar]
  20. Bedell MA, Jenkins NA, Copeland NG. Good genes in bad neighbourhoods. Nat Genet 1996; 12 : 229–32. [Google Scholar]
  21. Pfeifer D, Kist R, Dewar K, et al. Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9 : evidence for an extended control region. Am J Hum Genet 1999; 65 : 111–24. [Google Scholar]
  22. Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE. Nonsense-mediated decay approaches the clinic. Nat Genet 2004; 36 : 801–8. [Google Scholar]
  23. Roca X, Sachidanandam R, Krainer AR. Intrinsic differences between authentic and cryptic 5’ splice sites. Nucleic Acids Res 2003; 31 : 6321–33. [Google Scholar]
  24. Harland M, Mistry S, Bishop DT, Bishop JA. A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum Mol Genet 2001; 10 : 2679–86. [Google Scholar]
  25. Abkevich V, Zharkikh A, Deffenbaugh AM, et al. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet 2004; 41 : 492–507. [Google Scholar]
  26. Messiaen LM, Callens T, Mortier G, et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95 % of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000; 15 : 541–55. [Google Scholar]
  27. Andreutti-Zaugg C, Scott RJ, Iggo R. Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques. Cancer Res 1997; 57 : 3288–93. [Google Scholar]
  28. Tufarelli C, Stanley JA, Garrick D, et al. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet 2003; 34 : 157–65. [Google Scholar]
  29. Wittkopp PJ, Haerum BK, Clark AG. Evolutionary changes in cis and trans gene regulation. Nature 2004; 430 : 85–8. [Google Scholar]
  30. Han JS, Szak ST, Boeke JD. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 2004; 429 : 268–74. [Google Scholar]
  31. Hudder A, Werner R. Analysis of a Charcot-Marie-Tooth disease mutation reveals an essential internal ribosome entry site element in the connexin-32 gene. J Biol Chem 2000; 275 : 34586–91. [Google Scholar]
  32. Bulyk ML. Computational prediction of transcription-factor binding site locations. Genome Biol 2003; 5 : 201. [Google Scholar]
  33. Wasserman WW, Sandelin A. Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet 2004; 5 : 276–87. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.